RCMI Coordinating Center (RCMI CC) Header Logo

KiTani Parker-Lemieux

TitleFaculty, Division of Basic Pharmaceutical Sciences
Faculty RankAssistant Professor
InstitutionXavier University of Louisiana
DepartmentDBPS
AddressXavier University of Louisiana
1 Drexel Drive
DBPS
New Orleans LA 70125
Phone5045205331
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    The proposed research is relevant to public health because the characterization of exosomes secreted by noncancerous cells in the extracellular microenvironment would provide potential therapeutic targets for pharmacological intervention. Thus, the proposed research is relevant to the part of NIH’s mission that pertains to developing fundamental knowledge that will help to reduce the burdens of metatstatic breast disease.

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Israel BB, Tilghman SL, Parker-Lemieux K, Payton-Stewart F. Phytochemicals: Current strategies for treating breast cancer. Oncol Lett. 2018 May; 15(5):7471-7478. PMID: 29755596.
      Citations:    
    2. Carriere PP, Llopis SD, Naiki AC, Nguyen G, Phan T, Nguyen MM, Preyan LC, Yearby L, Pratt J, Burks H, Davenport IR, Nguyen TA, Parker-Lemieux K, Payton-Stewart F, Williams CC, Bou? SM, Burow ME, Collins-Burow B, Hilliard A, Davidson AM, Tilghman SL. Glyceollin I Reverses Epithelial to Mesenchymal Transition in Letrozole Resistant Breast Cancer through ZEB1. Int J Environ Res Public Health. 2015 Dec 22; 13(1):ijerph13010010. PMID: 26703648.
      Citations: 10     Fields:    Translation:HumansAnimalsCells
    3. Johnson KP, Yearby LA, Stoute D, Burow ME, Rhodes LV, Gray M, Carriere P, Tilghman SL, McLachlan JA, Ochieng J. In vitro and in vivo evaluation of novel anticancer agents in triple negative breast cancer models. J Health Care Poor Underserved. 2013 Feb; 24(1 Suppl):104-11. PMID: 23395947.
      Citations: 9     Fields:    Translation:HumansAnimalsCells
    4. Koochekpour S, Maresh GA, Katner A, Parker-Johnson K, Lee TJ, Hebert FE, Kao YS, Skinner J, Rayford W. Establishment and characterization of a primary androgen-responsive African-American prostate cancer cell line, E006AA. Prostate. 2004 Jul 01; 60(2):141-52. PMID: 15162380.
      Citations: 35     Fields:    Translation:HumansAnimalsCells
    5. Johnson KP, Rowe GC, Jackson BA, D'Agustino JL, Campbell PE, Guillory BO, Williams MV, Matthews QL, McKay J, Charles GM, Verret CR, Deleon M, Johnson DE, Cooke DB. Novel antineoplastic isochalcones inhibit the expression of cyclooxygenase 1,2 and EGF in human prostate cancer cell line LNCaP. Cell Mol Biol (Noisy-le-grand). 2001 Sep; 47(6):1039-45. PMID: 11785654.
      Citations: 1     Fields:    Translation:HumansCells
    Parker-Lemieux's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (44)
    Explore
    _
    Co-Authors (3)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

    For technical support please contact support